LYONS GARY A
Insider CIK 1123343 · RIGL Director · CYTX Director · KBIO Director · NGSX Director · NVUS Director · TVTX Director · VICL Director · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 5,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 4,100 | $63.27 | $259.4K | 62,400 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 900 | $63.86 | $57.5K | 61,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 5,000 | $17.44 | $87.2K | 66,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 5,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 900 | $63.86 | $57.5K | 61,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 4,100 | $63.27 | $259.4K | 62,400 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 5,000 | $17.44 | $87.2K | 66,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 500 | $64.16 | $32.1K | 61,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 2,600 | $63.50 | $165.1K | 62,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 1,900 | $62.53 | $118.8K | 64,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 5,000 | $17.44 | $87.2K | 66,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 500 | $64.16 | $32.1K | 61,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 2,600 | $63.50 | $165.1K | 62,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 1,900 | $62.53 | $118.8K | 64,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 5,000 | $17.44 | $87.2K | 66,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 2,624 | — | $0 | 2,624 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 1,284 | — | $0 | 1,284 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-21 | 2026-05-21 | 1,659 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-21 | 2026-05-21 | 1,659 | — | $0 | 122,141 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 61,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 8,000 | $16.33 | $130.6K | 65,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 8,000 | $41.07 | $328.6K | 57,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-12-03 | 2025-12-04 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-12-03 | 2025-12-04 | 15,000 | $47.89 | $718.4K | 135,482 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-12-03 | 2025-12-04 | 15,000 | $152.61 | $2.29M | 120,482 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-22 | 2025-05-22 | 1,435 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-22 | 2025-05-22 | 1,435 | — | $0 | 120,482 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,305 | — | $0 | 3,305 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 1,659 | — | $0 | 1,659 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 57,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2024-10-04 | 2024-10-04 | 40,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-04 | 21,179 | $14.35 | $303.9K | 69,821 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2024-10-04 | 2024-10-04 | 40,000 | $10.48 | $419.2K | 91,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-04 | 18,821 | $15.15 | $285.1K | 51,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-08-13 | 2024-08-15 | 11,570 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-13 | 2024-08-15 | 11,570 | $150.43 | $1.74M | 119,047 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-08-13 | 2024-08-15 | 11,570 | $42.76 | $494.7K | 130,617 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-07-16 | 2024-07-18 | 930 | — | $0 | 11,570 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-16 | 2024-07-18 | 930 | $150.03 | $139.5K | 119,047 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-07-16 | 2024-07-18 | 930 | $42.76 | $39.8K | 119,977 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 1,435 | — | $0 | 1,435 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 2,982 | — | $0 | 2,982 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-17 | 2024-05-21 | 2,100 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-17 | 2024-05-21 | 2,100 | — | $0 | 119,047 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-14 | 2024-05-16 | 12,500 | $42.76 | $534.5K | 12,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-14 | 2024-05-16 | 12,500 | $42.76 | $534.5K | 129,447 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-14 | 2024-05-16 | 12,500 | $135.63 | $1.70M | 116,947 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 51,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-22 | 2023-12-27 | 10,000 | $130.04 | $1.30M | 193,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-01 | 2023-12-05 | 5,000 | $12.98 | $64.9K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-01 | 2023-12-05 | 5,000 | $116.77 | $583.9K | 203,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-01 | 2023-12-05 | 5,000 | $12.98 | $64.9K | 208,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-09-12 | 2023-09-14 | 5,000 | $12.98 | $64.9K | 5,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-09-12 | 2023-09-14 | 5,000 | $12.98 | $64.9K | 208,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-09-12 | 2023-09-14 | 5,000 | $115.02 | $575.1K | 203,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-09-01 | 2023-09-06 | 5,000 | $12.98 | $64.9K | 10,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-09-01 | 2023-09-06 | 5,000 | $12.98 | $64.9K | 208,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-09-01 | 2023-09-06 | 5,000 | $110.06 | $550.3K | 203,697 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2023-05-26 | 2023-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2023-05-26 | 2023-07-12 | 25,000 | — | $0 | 75,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 4,290 | — | $0 | 4,290 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 2,100 | — | $0 | 2,100 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 44,500 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-05-01 | 2023-05-02 | 150,437 | — | $0 | 150,437 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-02-01 | 2023-02-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-10-31 | 2022-11-02 | 15,000 | $12.71 | $190.7K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-10-31 | 2022-11-02 | 15,000 | $114.76 | $1.72M | 203,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-10-31 | 2022-11-02 | 15,000 | $12.71 | $190.7K | 218,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-10-04 | 2022-10-05 | 5,000 | $110.54 | $552.7K | 203,697 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2022-05-20 | 2022-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2022-05-20 | 2022-05-23 | 25,000 | — | $0 | 50,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-05-18 | 2022-05-20 | 9,724 | — | $0 | 9,724 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2022-05-17 | 2022-05-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-04-25 | 2022-04-27 | 15,000 | $6.66 | $99.9K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-04-25 | 2022-04-27 | 15,000 | $6.66 | $99.9K | 223,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-04-25 | 2022-04-27 | 15,000 | $92.76 | $1.39M | 208,697 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2022-02-01 | 2022-02-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-10-07 | 2021-10-12 | 5,000 | $105.06 | $525.3K | 208,697 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2021-06-14 | 2021-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-06-10 | 2021-06-14 | 10,000 | $100.27 | $1.00M | 213,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-05-19 | 2021-05-20 | 8,833 | — | $0 | 8,833 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2021-05-19 | 2021-05-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2021-05-19 | 2021-05-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 37,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-26 | 2021-01-27 | 400 | $120.00 | $48.0K | 223,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 1,600 | $120.03 | $192.0K | 224,097 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-12-31 | 2021-01-05 | 5,967 | $0.78 | $4.7K | 18,762 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award | 2020-09-15 | 2020-09-17 | 11,934 | $0.81 | $9.7K | 24,729 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2020-09-11 | 2020-09-15 | 1,167 | — | $0 | 1,167 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-08-31 | 2020-09-02 | 692 | — | $0 | 0 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-08-31 | 2020-09-02 | 692 | — | $0 | 21,772 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-08-31 | 2020-09-02 | 346 | $0.94 | $325 | 21,426 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-08-31 | 2020-09-02 | 8,631 | $0.94 | $8.1K | 12,795 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-07-31 | 2020-08-04 | 692 | — | $0 | 692 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-07-31 | 2020-08-04 | 692 | — | $0 | 21,426 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-07-31 | 2020-08-04 | 346 | $0.92 | $318 | 21,080 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-06-30 | 2020-07-02 | 691 | — | $0 | 1,384 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-06-30 | 2020-07-02 | 346 | $1.00 | $346 | 20,734 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-06-30 | 2020-07-02 | 691 | — | $0 | 21,080 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 4,333 | — | $0 | 4,333 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award | 2020-06-03 | 2020-06-05 | 17,261 | — | $0 | 20,389 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-05-31 | 2020-06-05 | 692 | — | $0 | 692 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-05-31 | 2020-06-05 | 346 | $1.16 | $401 | 3,128 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-05-31 | 2020-06-05 | 692 | — | $0 | 3,474 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-05-19 | 2020-05-21 | 6,018 | — | $0 | 6,018 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2020-05-15 | 2020-05-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 34,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-04-30 | 2020-06-05 | 692 | — | $0 | 692 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-04-30 | 2020-06-05 | 346 | $1.20 | $415 | 2,782 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-04-30 | 2020-06-05 | 692 | — | $0 | 3,128 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-03-31 | 2020-06-05 | 691 | — | $0 | 691 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-03-31 | 2020-06-05 | 346 | $1.19 | $412 | 2,436 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-03-31 | 2020-06-05 | 691 | — | $0 | 2,782 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-02-29 | 2020-06-05 | 692 | — | $0 | 692 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-02-29 | 2020-06-05 | 346 | $2.93 | $1.0K | 2,091 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-02-29 | 2020-06-05 | 692 | — | $0 | 2,437 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2020-02-14 | 2020-06-05 | 3,491 | — | $0 | 3,491 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-06-05 | 8,333 | — | $0 | 8,333 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-06-05 | 2,167 | — | $0 | 2,167 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2020-02-14 | 2020-06-05 | 1,746 | $1.16 | $2.0K | 1,745 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2020-02-14 | 2020-06-05 | 3,491 | — | $0 | 3,491 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 8,333 | $1.16 | $9.7K | 8,333 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 2,167 | $1.16 | $2.5K | 2,167 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-11-08 | 2019-11-13 | 5,000 | $110.00 | $550.0K | 225,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-11-01 | 2019-11-05 | 5,000 | $100.22 | $501.1K | 230,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-07-30 | 2019-07-31 | 10,000 | $92.07 | $920.7K | 235,697 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2019-05-23 | 2019-05-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-05-22 | 2019-05-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 31,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-11-02 | 2018-11-05 | 15,000 | $114.41 | $1.72M | 245,697 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-06-13 | 2018-06-15 | 15,000 | $99.24 | $1.49M | 260,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-05-24 | 2018-05-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2018-05-23 | 2018-05-24 | 6,500 | — | $0 | 6,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2018-05-17 | 2018-05-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 29,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-04-03 | 2018-04-05 | 15,000 | $7.05 | $105.8K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-04-03 | 2018-04-05 | 15,000 | $7.05 | $105.8K | 277,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2018-04-03 | 2018-04-05 | 1,369 | $77.23 | $105.7K | 275,697 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-02-15 | 2018-02-20 | 5,000 | $84.67 | $423.4K | 262,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-02-05 | 2018-02-07 | 5,000 | $83.08 | $415.4K | 267,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-12-01 | 2017-12-05 | 10,000 | $72.92 | $729.2K | 272,066 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1 | — | $0 | 0 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1 | — | $0 | 1 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2018-02-09 | 1,800 | — | $0 | 1,800 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2017-05-25 | 2017-05-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-05-22 | 2017-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 26,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-05-12 | 2017-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-02-14 | 2017-02-15 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-02-14 | 2017-02-15 | 15,000 | $3.40 | $51.0K | 282,066 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VICL VICAL INC | S Sale | 2016-12-05 | 2016-12-07 | 7,078 | $2.30 | $16.3K | 7,828 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-16 | 950 | — | $0 | 950 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-16 | 1,900 | — | $0 | 0 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise | 2016-06-15 | 2016-06-16 | 1,900 | — | $0 | 4,358 | SEC↗ |
| VICL VICAL INC | P Buy | 2016-06-03 | 2016-06-06 | 7,078 | $4.39 | $31.1K | 14,906 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2016-05-20 | 2016-05-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 24,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-05-11 | 2016-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2016-05-06 | 2016-05-10 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2016-05-06 | 2016-05-10 | 15,000 | $3.07 | $46.0K | 267,066 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-04 | 53,820 | — | $0 | 99,820 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-09-18 | 2015-09-21 | 10,000 | $55.00 | $550.0K | 257,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-09-18 | 2015-09-21 | 5,000 | $54.66 | $273.3K | 252,066 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-07-10 | 2015-07-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-06-08 | 2015-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2015-06-08 | 2015-06-10 | 2,000 | — | $0 | 22,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-05-28 | 2015-06-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2015-05-21 | 2015-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VICL VICAL INC | A Award | 2015-05-21 | 2015-05-26 | 7,500 | $0.01 | $75 | 78,281 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2015-05-13 | 2015-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2015-05-08 | 2015-05-18 | 12,440 | — | $0 | 12,440 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-03-24 | 2015-03-24 | 30,000 | $41.53 | $1.25M | 267,066 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2015-02-13 | 2015-02-13 | 25,000 | — | $0 | 46,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-02-10 | 2015-02-11 | 7,500 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-02-10 | 2015-02-11 | 7,500 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2015-02-10 | 2015-02-11 | 996 | $35.83 | $35.7K | 297,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-02-10 | 2015-02-11 | 7,500 | $4.76 | $35.7K | 298,062 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-02-10 | 2015-02-11 | 7,500 | $4.76 | $35.7K | 298,062 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2015-02-10 | 2015-02-11 | 996 | $35.83 | $35.7K | 297,066 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-01-20 | 2015-01-22 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-01-20 | 2015-01-22 | 7,500 | $4.76 | $35.7K | 291,664 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2015-01-20 | 2015-01-22 | 1,102 | $32.38 | $35.7K | 290,562 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2014-10-08 | 2014-10-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2014-10-08 | 2014-10-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-09-15 | 2014-09-17 | 20,000 | $15.66 | $313.2K | 284,164 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2014-06-18 | 2014-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-05-22 | 2014-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2014-05-22 | 2014-05-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VICL VICAL INC | A Award | 2014-05-22 | 2014-05-23 | 7,500 | $0.01 | $75 | 70,781 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2014-05-21 | 2014-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2014-05-19 | 2014-05-20 | 3,409 | — | $0 | 24,409 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-03-07 | 2014-03-10 | 85,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2014-03-07 | 2014-03-10 | 53,331 | $17.50 | $933.3K | 304,164 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-03-07 | 2014-03-10 | 85,000 | $10.98 | $933.3K | 357,495 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2013-10-07 | 2013-10-09 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2013-10-07 | 2013-10-09 | 21,000 | — | $0 | 21,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2013-05-23 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2013-05-23 | 2013-05-28 | 39,619 | — | $0 | 284,678 | SEC↗ |
| VICL VICAL INC | P Buy | 2013-05-23 | 2013-05-28 | 5,953 | $0.01 | $60 | 63,281 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2013-05-15 | 2013-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-04-30 | 2013-05-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-06-07 | 2012-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2012-05-24 | 2012-05-29 | 46,622 | — | $0 | 251,309 | SEC↗ |
| VICL VICAL INC | P Buy | 2012-05-24 | 2012-05-29 | 7,328 | $0.01 | $73 | 57,328 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-02-07 | 2012-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |